Short-Term Debt to Equity Ratio: Viking Therapeutics (VKTX)
This VKTX price chart on the GURU.Markets platform, where the indicator stands at 0.02, illustrates the price action of Viking Therapeutics (VKTX) as it battles global behemoths for leadership in metabolism therapy. The business relies on third-party laboratories and plants, minimizing internal costs through strategic outsourcing. An extensive network of contractors guarantees system stability, eliminating component shortages and ensuring high margins.
Analytical breakdowns for vikingtherapeutics.com (VKTX)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Equity Ratio Viking Therapeutics|VKTX - Long-Term Debt to Equity|Short-Term Debt to Capital Viking Therapeutics, Inc.|VKTX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Viking Therapeutics Inc|VKTX - Company Long-Term Debts|Company Short-Term Debts Viking Therapeutics|Quick Liquidity vikingtherapeutics.com
- company profitability and valuation multiples indicators:
Basic company analysis:VKTX Viking Pharma
For biopharmaceutical innovator Viking Therapeutics (VKTX), which invests in obesity-focused R&D, liquidity control is critical to maintaining the pace of research. This metric is calculated as the ratio of short-term liabilities to equity, determining the business's ability to settle urgent loans without compromising financial stability. By analyzing this daily chart of short-term debt to equity, an investor can assess the debt load risk relative to the issuer's own equity.
Analysis of competing companies
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Supernus Pharma (SUPN) - Short-Term Debt to Equity|Current Liabilities to Capital Catalyst Corp (CPRX)|Short-Term Debt to Equity Ratio DNLI|Short-Term Debt to Equity HRMY|Short-Term Debt to Capital BHVN|Short-Term Debt to Capital Coefficient Amylyx Pharmaceuticals Inc|Short-Term Debt to Equity Trevi Pharma TRVI|Short-Term Debt to Capital Praxis Corp PRAX|Anavex Life Sciences - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient ceribell.com CBLL|Prothena Corp (PRTA) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ALEC|ANNX (Annexon Inc.) - Short-Term Debt to Capital|OMER - Short-Term Indebtedness to Equity|Short-Term Debt to Equity Ratio NGNE (Neurogene Inc.)|ACIU (acimmune.com) - Ratio of Short-Term Indebtedness to Capital|Voyager Therapeutics, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio NMRA (Neumora)|Scilex Holding Co. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital TVGN (Tevogen Bio Inc.)|ACOG: Short-Term Debt to Capital|Current Liabilities to Capital cogrx.com (CGTX)|Short-Term Debt to Equity Inhibikase Therapeutics, Inc.|SAVA: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ASRT|Short-Term Debt to Capital coyatherapeutics.com (COYA)|Short-Term Debt to Equity Vistagen VTGN|OVID (Ovid Therapeutics Inc) - Current Liabilities to Equity|Acumen Pharmaceuticals, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital CervoMed, Inc.|ATHE (alteritytherapeutics.com) - Short-Term Debt to Equity Ratio|Clene (CLNN) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PEPG|JUNS (jupiterneurosciences.com) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital RLMD|Short-Term Debt to Capital Coefficient Annovis Bio Inc|Short-Term Debt to Capital GRCE (Grace Therapeutics)|AIFF - Short-Term Debt to Equity Ratio|KLTO - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient NeuroSense Therapeutics NRSN|RVPH (Reviva Pharmaceuticals Holdings, Inc.) - Short-Term Debt to Equity Ratio|MTVA (MetaVia) - Short-Term Debt to Equity|Short-Term Debt to Equity NeurAxis, Inc|Short-Term Debt to Capital Helius Medical Technologies Inc.|Short-Term Debt to Equity Ratio PASG (Passage Bio, Inc.)|Short-Term Loans to Capital Ratio NEUP|Minerva Neurosciences, Inc. - Short-Term Debt to Equity Ratio|ATHA: Short-Term Debt to Capital Ratio|ADXN - Short-Term Debt to Equity|ALZN (Alzamend Neuro, Inc.) - Short-Term Debt to Capital Ratio|CYCN: Short-Term Debt to Capital|Current Liabilities to Capital Protagenic Therapeutics, Inc. (PTIX)|Short-Term Debt to Equity Ratio KTTA|Short-Term Debt to Capital Cortigent Medical|Short-Term Debt to Equity Avenue Therapeutics, Inc (ATXI)|BCLI (BrainStorm Cell Therapeutics Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Cara Therapeutics, Inc. CARA|chromocell.com (CHRO) - Current Liabilities to Capital|ELYM: Short-Term Debt to Equity Ratio|ITCI: Short-Term Debt to Equity|LBPH: Short-Term Debt to Capital|MRNS - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity NKGen Biotech, Inc.|Short-Term Debt to Capital neurobopharma.com|Short-Term Debt to Capital SAGE|Short-Term Debt to Capital Coefficient Synaptogenix Inc.|Short-Term Debt to Equity Trevena, Inc TRVN|VIGL: Short-Term Debt to Capital Ratio|Anew Medical, Inc. - Short-Term Debt to Capital|Short-Term Indebtedness to Equity cerevel.com (CERE)